KRYSTAN VERNETTI: Open Payments
NPI 1205619830 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$483 in 28 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $43 · 2025 $483
Food & beverage: $483
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $141 |
| Amgen Inc. | 4 | $70 |
| Aimmune Therapeutics, Inc. | 4 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Edwards Lifesciences Corporation | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| Globus Medical, Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| PFIZER INC. | 1 | $17 |
Products named: VRAYLAR, ZENPEP, EVENITY, LINZESS, CREON, REXULTI, SAPIEN 3 Ultra RESILIA, VOQUEZNA.
Industry payments across AZ — which companies pay providers there.
